Abstract
To assess the trends and factors associated with the price at market entry of new molecular entities (NMEs) with oral formulations and chronic use approved by the FDA between 1980 and 2021.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
